NCT02878200View on ClinicalTrials.gov

RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission

NACompletedINTERVENTIONAL
Enrollment

2,236

Participants

Timeline

Start Date

November 4, 2016

Primary Completion Date

December 18, 2018

Study Completion Date

July 16, 2020

Conditions
Malaria
Interventions
BIOLOGICAL

dihydroartemisinin-piperaquine

A treatment course of DHAP consists of three doses taken daily. Treatment doses for household members will be prepared based on measured weight

Trial Locations (1)

Unknown

Health Centres in North Bank Region, North Bank Region

All Listed Sponsors
collaborator

Institute of Tropical Medicine, Belgium

OTHER

collaborator

University of Sheffield

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT02878200 - RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria Transmission | Biotech Hunter | Biotech Hunter